Publicaciones (24) Publicaciones de JAVIER PALAZUELOS DIEGO

2022

  1. Cannabinoid CB1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse

    Frontiers in Neuroanatomy, Vol. 16

  2. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

2021

  1. Erratum: TGFb Signaling Regulates the Timing of CNS Myelination by Modulating Oligodendrocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1 (Journal of Neuroscience (2014) (7917-7930) DOI: 10.1523/JNEUROSCI.0363-14.2014)

    Journal of Neuroscience

  2. Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain

    British Journal of Pharmacology, Vol. 178, Núm. 20, pp. 4176-4192

  3. Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    GLIA, Vol. 69, Núm. 3, pp. 532-545

2018

  1. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders

    Biochemical Pharmacology, Vol. 157, pp. 85-96

2015

  1. Oligodendrocyte regeneration and CNS remyelination require TACE/ADAM17

    Journal of Neuroscience, Vol. 35, Núm. 35, pp. 12241-12247

2014

  1. TACE/ADAM17 is essential for oligodendrocyte development and CNS myelination

    Journal of Neuroscience, Vol. 34, Núm. 36, pp. 11884-11896

  2. TGFβ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1

    Journal of Neuroscience, Vol. 34, Núm. 23, pp. 7917-7930

2013

  1. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system

    International Journal of Neuropsychopharmacology, Vol. 16, Núm. 6, pp. 1407-1419

2012

  1. CB 2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling

    Journal of Biological Chemistry, Vol. 287, Núm. 2, pp. 1198-1209

  2. The CB1 cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis

    Journal of Neuroscience, Vol. 32, Núm. 47, pp. 16651-16665

2011

  1. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

    Brain, Vol. 134, Núm. 1, pp. 119-136

2009

  1. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

    Brain, Vol. 132, Núm. 11, pp. 3152-3164

  2. The endocannabinoid system and the regulation of neural development: Potential implications in psychiatric disorders

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Núm. 7, pp. 371-382

2008

  1. Mechanisms of control of neuron survival by the endocannabinoid system

    Current Pharmaceutical Design, Vol. 14, Núm. 23, pp. 2279-2288

  2. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis (Journal of Biological Chemistry (2007) 282, (23892-23898))

    Journal of Biological Chemistry

  3. The CB2 cannabinoid receptor controls myeloid progenitor trafficking: Involvement in the pathogenesis of an animal model of multiple sclerosis

    Journal of Biological Chemistry, Vol. 283, Núm. 19, pp. 13320-13324

2007

  1. Prevention of osteoporosis: Four-year follow-up of a cohort of postmenopausal women treated with an ossein-hydroxyapatite compound

    Clinical Drug Investigation, Vol. 27, Núm. 4, pp. 227-232

  2. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis

    Journal of Biological Chemistry, Vol. 282, Núm. 33, pp. 23892-23898